Related by context. All words. (Click for frequent words.) 75 dose cytarabine 73 dose melphalan 72 dose cyclophosphamide 72 melphalan prednisone 71 chlorambucil 71 dose clopidogrel 70 CHOP chemotherapy 70 dose atorvastatin 70 doxorubicin cyclophosphamide 70 decitabine 70 azacitidine 69 VELCADE melphalan 69 doxorubicin docetaxel 69 plus dexamethasone 69 5-FU/LV 69 docetaxel chemotherapy 69 alfa 2a 69 low dose dexamethasone 69 standard chemotherapy regimen 69 daunorubicin 69 Doxil ® 68 Peg IFN 68 low dose cytarabine 68 ritonavir boosted 68 carboplatin paclitaxel 68 pegylated liposomal doxorubicin 68 gemcitabine carboplatin 68 mycophenolate mofetil 68 relapsed MM 68 FOLFIRI 68 dexamethasone Decadron 68 FOLFOX4 68 cisplatin chemotherapy 68 Tarceva TM 67 Fludara 67 gemcitabine cisplatin 67 abacavir lamivudine 67 postoperative chemotherapy 67 dacarbazine 67 Folfox 67 certolizumab 67 interferon alfa 2b 67 sorafenib Nexavar 67 FOLFOX 67 lenalidomide Revlimid R 67 tirofiban 67 EBRT 67 bendamustine 67 nadolol 67 darunavir ritonavir 67 idarubicin 67 PSA nadir 67 chemoradiotherapy 67 grade gliomas 67 DOXIL 67 temsirolimus 66 dose interleukin 66 mg m² 66 liposomal doxorubicin 66 Lenalidomide 66 XELOX 66 dose colchicine 66 pegylated interferon alfa 66 grade glioma 66 placebo dexamethasone 66 clodronate 66 dose cohorts 66 plus prednisone 66 pertuzumab 66 galiximab 66 vinorelbine 66 estramustine 66 nab paclitaxel 66 neoadjuvant 66 fluvastatin 66 etoposide 66 unfractionated heparin UFH 66 mg kg dose 66 plus prednisone prednisolone 66 refractory chronic lymphocytic 66 mg QD 66 Xelox 66 5FU 66 ULORIC 66 Flu Cy 66 azathioprine 66 cisplatin 66 Pegylated Liposomal Doxorubicin 66 dose cohort 65 pCR 65 ara C 65 steroid dexamethasone 65 erlotinib Tarceva ® 65 mRCC 65 grade cervical intraepithelial 65 neoadjuvant chemotherapy 65 peginterferon alfa 2b 65 anthracycline taxane 65 fluorouracil 65 Pegasys peginterferon alfa 2a 65 Free Survival PFS 65 tipranavir r 65 chemotherapy docetaxel 65 oral rivaroxaban 65 DMARD 65 sorafenib Nexavar ® 65 ribavirin RBV 65 PEG IFN 65 docetaxel Taxotere ® 65 Aptivus ® 65 docetaxel Taxotere 65 Pegasys ® 65 pegylated interferon alfa 2b 65 gemcitabine Gemzar 65 CIMZIA TM 65 FluCAM 65 infusional 5-FU/LV 65 gemtuzumab ozogamicin 65 CLL SLL 65 adalimumab 65 ABVD 65 neurologic progression 65 pegfilgrastim 65 YERVOY 65 TPV r 65 dose methotrexate 65 Ceplene/IL-2 65 Platinol ® cisplatin 65 daily subcutaneous injections 65 biologic DMARD 65 chemotherapeutic regimens 65 MGd 65 interferon alfa 2a 65 trabectedin 65 teriflunomide 65 mg/m2 dose 65 gemcitabine chemotherapy 64 oblimersen 64 preoperative chemotherapy 64 5 FU leucovorin 64 pegylated interferon alpha 64 methotrexate therapy 64 Zometa hazard 64 dimeglumine 64 protease inhibitor PI 64 gemcitabine 64 complete cytogenetic response 64 achieved ACR# 64 DAPT 64 idraparinux 64 CCyR 64 grade cervical dysplasia 64 mitoxantrone plus 64 weekly subcutaneous injections 64 mitomycin 64 follicular NHL 64 LPV r 64 comparator arm 64 serum urate 64 eplerenone 64 iodixanol 64 divalproex sodium 64 thalidomide Thalomid 64 evaluating tivozanib 64 octreotide 64 paclitaxel eluting stents 64 CsA 64 unfractionated heparin 64 CANCIDAS 64 PegIFN RBV 64 bevacizumab Avastin 64 ATACAND 64 chemotherapeutic regimen 64 TAXUS Express Stent 64 cyclophosphamide 64 bolus dose 64 iniparib 64 interferon alfa 64 efavirenz EFV 64 locoregional 64 dexamethasone 64 fluticasone salmeterol 64 dose corticosteroids 64 cyclophosphamide doxorubicin vincristine 64 5 Fluorouracil 64 mg hydrochlorothiazide 64 oral clodronate 64 sunitinib malate 64 VIDAZA 64 3TC lamivudine Epivir 64 paclitaxel chemotherapy 64 salmeterol fluticasone 64 ixabepilone 64 mcg dose 64 topotecan 64 lenalidomide 64 lispro 64 cisplatin gemcitabine 64 docetaxel 64 FOLFOX6 chemotherapy regimen 64 Vidaza azacitidine 64 TACE 64 atorvastatin #mg 64 dose regimens 64 infliximab monotherapy 64 ABC/3TC 64 paclitaxel carboplatin 64 pyrazinamide 64 BEACOPP 64 azacytidine 64 receiving highly emetogenic 64 nilotinib 64 relapsed refractory multiple myeloma 64 median PFS 64 pomalidomide 63 peg IFN 63 Pemetrexed 63 Hazard Ratio 63 adalimumab Humira 63 adriamycin 63 8mg/kg 63 dose ritonavir 63 mitoxantrone chemotherapy 63 neutrophil counts 63 docetaxel Taxotere R 63 goserelin 63 DMARD therapy 63 sustained virologic response 63 alpha 2b 63 APTIVUS r 63 CLORETAZINE TM VNP#M 63 gemcitabine Gemzar ® 63 metastatic renal cell carcinoma 63 CRp 63 virologic failure 63 Amrubicin 63 tenofovir emtricitabine 63 Peginterferon 63 TMC# r 63 receptor tyrosine kinase inhibitor 63 neostigmine 63 virological failure 63 5-fluorouracil/leucovorin 63 Capecitabine 63 paricalcitol 63 partial remissions 63 Interferon alfa 63 octreotide LAR 63 Trastuzumab 63 chemoradiation 63 receiving VICTRELIS 63 dalteparin 63 relapsing multiple sclerosis 63 plus gemcitabine 63 cytarabine daunorubicin 63 angiotensin converting enzyme inhibitor 63 irbesartan 63 subcutaneously administered 63 vinca alkaloid 63 peginterferon alfa 2a Pegasys 63 CIMZIA ™ 63 remission CR 63 zonisamide SR 63 tiotropium 63 Telintra 63 lopinavir r 63 ritonavir boosted atazanavir 63 bevacizumab Avastin ® 63 pamidronate 63 #mg dose [003] 63 #mg/m# [002] 63 concurrent chemoradiation 63 Gemcitabine 63 Pegasys plus Copegus 63 capecitabine Xeloda 63 imatinib therapy 63 temozolomide 63 fluoropyrimidine 63 irinotecan chemotherapy 63 Xeloda ® 63 methotrexate monotherapy 63 Fludarabine 63 Irinotecan 63 locoregional recurrence 63 #mg/m# [001] 63 nicardipine 63 paclitaxel Taxol ® 63 tenecteplase 63 lanthanum carbonate 63 etanercept Enbrel 63 platelet inhibitor 63 Cyclophosphamide 63 mcg kg 63 viral kinetics 63 TAXUS Liberte Long 63 pemetrexed 63 saline placebo 63 monotherapy 63 imatinib 63 ribavirin therapy 63 generation purine nucleoside 63 IFN α 63 rFSH 63 PREZISTA r 63 mg BID 63 EpCAM expression 63 weight heparin LMWH 63 amprenavir 63 relapsed multiple myeloma 63 intravesical therapy 63 febrile neutropenia 63 PegIFN 63 boosted protease inhibitor 63 piperacillin tazobactam 63 reteplase 63 bortezomib Velcade R 63 biochemical relapse 63 valsartan amlodipine 63 Torisel 63 Taxotere ® 63 ARB telmisartan 63 relapsed myeloma 63 pegylated alpha interferon 63 PEGINTRON TM 63 lapatinib Tykerb 63 cilengitide 63 dacarbazine chemotherapy 63 TAXOTERE R 63 sunitinib 63 amrubicin 63 Pegylated Interferon 63 fulvestrant 63 bevacizumab 63 amoxicillin clavulanate 63 paclitaxel Taxol 63 DOXIL ® 62 ACTEMRA TM 62 LMWH 62 recurrent glioblastoma multiforme 62 adjuvant tamoxifen 62 Neoadjuvant 62 mCi kg 62 Darunavir 62 aspirin heparin 62 chemoradiation therapy 62 epirubicin 62 XIENCE V PROMUS Stent 62 ZACTIMA 62 Engerix B 62 Bezielle 62 peginterferon alfa 2a 62 HGS# 62 peginterferon alpha 2a 62 TO AVOID PREGNANCY WHILE 62 baseline LDH 62 Herceptin trastuzumab 62 tolvaptan 62 heavily pretreated 62 Pharmacokinetics PK 62 ritonavir boosted protease inhibitor 62 smoldering multiple myeloma 62 doxorubicin HCl liposome injection 62 cyclophosphamide chemotherapy 62 alpha 2a 62 eribulin mesylate 62 cidofovir 62 COPEGUS 62 severe neutropenia 62 3mg/kg 62 Hycamtin ® 62 standard chemotherapy regimens 62 eptifibatide 62 IFN beta 62 stage IIIb IV 62 virologic response 62 MAGE A3 ASCI 62 irinotecan cisplatin 62 atazanavir ritonavir 62 PEG interferon 62 IIIa inhibitor 62 antithymocyte globulin 62 metastatic malignant 62 heavily pretreated patients 62 metastatic CRC 62 free survival PFS 62 prednisone prednisolone 62 imipenem 62 intravenous bisphosphonates 62 adjuvant cisplatin 62 methotrexate MTX 62 sustained virological response 62 lenalidomide dexamethasone 62 symptomatic VTE 62 mg ustekinumab 62 BARACLUDE ® 62 GnRH agonist 62 pegylated interferon peg IFN 62 stavudine d4T 62 neoadjuvant treatment 62 ritonavir boosted lopinavir 62 #mg QD [001] 62 fosamprenavir 62 aprepitant 62 MabCampath 62 chemotherapy cisplatin 62 Cloretazine 62 Exemestane 62 FOLFOX6 62 untreated multiple myeloma 62 sulphonylurea 62 paclitaxel cisplatin 62 xenograft models 62 AEGR 62 Epirubicin 62 rituximab 62 FOLFOX4 alone 62 TNF antagonist 62 NATRECOR ® 62 eribulin 62 Cloretazine ® 62 cytotoxic chemotherapy 62 mitoxantrone 62 Gemzar gemcitabine 62 lumbar spine BMD 62 everolimus eluting stents 62 clomipramine 62 ASCT 62 melphalan 62 Platinol ® 62 Platinol 62 irinotecan doxorubicin oxaliplatin paclitaxel 62 taxotere 62 serum HBV DNA 62 letrozole Femara 62 metastatic colorectal carcinoma 62 Fulvestrant 62 AZT zidovudine Retrovir 62 telaprevir dosed 62 PSMA ADC 62 olmesartan 62 interferon beta therapy 62 mg/m2/day 62 Teriflunomide 62 cytarabine 62 pegylated interferon alpha 2a 62 chemotherapeutic drug 62 hematologic toxicity 62 aldosterone antagonists 62 autoantibody positive 62 intravenous dosing 62 FIRMAGON 62 metformin sulfonylurea 62 trastuzumab 62 axitinib 62 glycoprotein IIb IIIa inhibitor 62 FOLPI 62 insulin detemir 62 q#h 62 dasatinib Sprycel 62 fludarabine 62 temozolomide TMZ 62 gefitinib Iressa 62 inhaled budesonide 62 liposomal formulation 62 neratinib 62 APTIVUS 62 #mg QD [002] 62 HBeAg seroconversion 62 6 mercaptopurine 62 Erlotinib 62 rosuvastatin #mg 62 Xanafide 62 PSADT 62 Omacetaxine 62 LEXIVA r 62 platelet reactivity 62 aspirin clopidogrel 62 Azacitidine 62 adenoma recurrence 62 pioglitazone HCl 62 aspartate aminotransferase AST 62 serum phosphate 62 YONDELIS 62 peg interferon 61 ertapenem 61 ACE inhibitor ramipril 61 bicalutamide 61 AST ALT 61 Copegus ribavirin 61 valsartan 61 Natalizumab 61 administered subcutaneously 61 raltegravir 61 erlotinib Tarceva 61 intravenous cyclophosphamide 61 tamoxifen therapy 61 sitagliptin 61 adefovir 61 systemic bioavailability 61 Decitabine 61 TORISEL 61 morphometric vertebral fractures 61 anastrazole 61 oral allopurinol 61 medroxyprogesterone acetate 61 coadministration 61 PASI scores 61 Alkeran 61 zoledronic acid 61 intermittent dosing 61 FUSILEV enhances 61 reinfarction 61 Elitek 61 EGFR TKI 61 darunavir r 61 cisplatin vinorelbine 61 FEMALES SHOULD BE ADVISED 61 degarelix 61 urate lowering 61 thiazide diuretic 61 leucovorin 61 verapamil 61 Topotecan 61 DMARDs 61 Gemzar ® 61 dosing cohort 61 mycophenolate mofetil MMF 61 NovoTTF 61 GP IIb IIIa inhibitors 61 BENICAR HCT 61 PREZISTA rtv 61 moderate renal impairment 61 ancrod 61 azilsartan medoxomil 61 response CCyR 61 4mg/kg 61 argatroban 61 KRAS mutations occur 61 elotuzumab 61 d4T stavudine Zerit 61 macrolide antibiotic 61 plus ribavirin 61 bupropion SR 61 androgen deprivation 61 flutamide 61 dacarbazine DTIC 61 Femara letrozole 61 Paraplatin ® 61 antithrombotic 61 CR nPR 61 autologous stem cell 61 Median PFS 61 fluorouracil leucovorin 61 5 FU 61 Melphalan 61 binary restenosis 61 leukemia AML 61 follicular lymphoma FL 61 gadobutrol 61 sorafenib tablets 61 remission induction 61 peginterferon 61 cangrelor 61 demonstrated antitumor activity 61 rFVIIa 61 cabazitaxel 61 intravesical 61 Mylotarg 61 ® lenalidomide 61 #mg q8h 61 nanomolar 61 chemotherapy gemcitabine 61 radiochemotherapy 61 ZD# [001] 61 Jevtana 61 5 fluorouracil leucovorin 61 Neulasta ® 61 intravenously administered 61 CR CRu 61 Bevacizumab 61 #mg BID [001] 61 dose Ara 61 MCyR 61 Mitoxantrone 61 mcg Albuferon 61 bortezomib Velcade 61 dasatinib 61 hA# 61 tumor progression TTP 61 lanreotide 61 sargramostim 61 noninferior 61 definite stent thrombosis 61 pharmacologically active isomer 61 #mg/day [001] 61 androgen suppression 61 TYKERB 61 trastuzumab Herceptin 61 RAPAFLO 61 caspofungin 61 maximally tolerated dose 61 Doxil 61 chlorthalidone 61 biochemical recurrence 61 #mg dose [001] 61 nitazoxanide 61 adjuvant radiation 61 GPIIb IIIa inhibitors 61 subcutaneous SC 61 visilizumab 61 basiliximab 61 TTF Therapy 61 peginterferon alfa 61 rapid virologic response 61 BRIM2 61 assessing T DM1 61 fenofibric acid 61 tinidazole 61 liposomal amphotericin B 61 myeloablative 61 TDF FTC 61 Median progression 61 mg kg BID 61 adecatumumab 61 active comparator 61 fibrinolytic therapy 61 mapatumumab 61 adefovir dipivoxil 61 undetectable HBV DNA 61 oral levofloxacin 61 alkylating agent 61 Dacogen decitabine 61 calcineurin inhibitor 61 NRTIs 61 tipranavir 61 ALT normalization 61 ibandronate 61 peak plasma concentrations 61 prospectively defined 61 pegylated interferons 61 colorectal liver metastases 61 NATRECOR R 61 corticosteroid dexamethasone 61 vincristine doxorubicin 61 #mg ATC 61 MetMAb 61 REVLIMID lenalidomide 61 entecavir 61 leuprorelin 61 pegylated liposomal doxorubicin PLD 61 surrogate endpoint 61 dasatinib Sprycel ® 61 Cytoxan 61 #Gy 61 histologically confirmed 61 seropositive patients 61 doxorubicin 61 budesonide formoterol 61 Halaven 61 FOLFIRI alone 61 LHRH agonists 61 bortezomib 61 Peginterferon alfa 2b 61 cinacalcet 61 serum calcium levels 61 Taxotere docetaxel 61 complete cytogenetic 60 interferon ribavirin 60 epoetin alpha 60 dose prednisone 60 thalidomide dexamethasone 60 intravenous bolus 60 diagnosed multiple myeloma 60 sorafenib 60 mg qd 60 platelet inhibition 60 mcg albinterferon alfa 2b 60 plus methotrexate 60 metastatic HRPC 60 bevacizumab Avastin R 60 acromegalic patients 60 VAPRISOL 60 rHuPH# 60 mcg BID 60 vandetanib 60 epirubicin cyclophosphamide 60 Camptosar ® 60 PEGylated interferon 60 Gefitinib 60 NPH insulin 60 adjuvant therapy 60 Cisplatin 60 paclitaxel poliglumex 60 5 fluorouracil 60 metastatic GIST 60 HSCT 60 Fludara ® 60 prednisone CHOP 60 custirsen 60 Triapine R 60 sorafenib Nexavar R 60 posaconazole 60 Combination therapy 60 Bortezomib 60 tocilizumab 60 mycophenolic acid 60 prior chemotherapy regimens 60 relapsed refractory 60 titrated glipizide 60 Phase Ib clinical 60 infusional 60 amphotericin B 60 pharmacokinetics PK 60 mCi 60 rizatriptan 60 G CSF 60 PREZISTA ritonavir 60 insulin lispro 60 oral diclofenac 60 taxane chemotherapy 60 Dasatinib 60 recurrent GBM patients 60 serum creatinine levels 60 ELOXATIN 60 immunomodulatory therapy 60 + PH# 60 desvenlafaxine succinate 60 quetiapine 60 crizotinib PF # 60 dose Iluvien 60 denileukin diftitox 60 evaluable subjects 60 Temsirolimus 60 NRTI 60 Molecular Weight Heparin 60 octreotide acetate 60 randomized multicenter Phase III 60 plasma uric acid 60 hsCRP levels 60 % CI #.#-#.# [007] 60 PEGASYS ® 60 Interferon beta 1a 60 SCH # 60 alteplase 60 #mg dose [002] 60 nucleoside naive patients 60 Rituxan rituximab 60 tapentadol IR 60 prednisone VcMP 60 intratumoral 60 Velcade bortezomib 60 KRAS wild 60 Taxotere chemotherapy 60 Sanofi Aventis Taxotere 60 luteinizing hormone releasing 60 sirolimus eluting stents 60 capecitabine 60 INCB# [001] 60 anthracycline therapy 60 nevirapine Viramune 60 ug kg 60 nelfinavir 60 angiotensin II receptor blocker 60 paclitaxel Taxol R 60 oral chemotherapeutic agent 60 TELCYTA 60 eculizumab therapy 60 endoscopic remission 60 colorectal adenoma 60 QT QTc 60 #mg doses [002] 60 refractory NSCLC 60 IMiDs ® compound 60 hepatic metastases 60 Navelbine ® 60 investigational protease inhibitor 60 HIV RNA 60 VIRAMUNE 60 radiotherapy RT 60 TREDAPTIVE 60 Eli Lilly Gemzar 60 sirolimus eluting stent 60 candesartan cilexetil 60 pain palliation 60 plus 5-FU/LV 60 esomeprazole 60 ascending dose 60 angiotensin receptor blocker ARB 60 urate lowering therapy 60 golimumab CNTO 60 oral Hycamtin 60 patients evaluable 60 hepatocellular carcinomas 60 glycated hemoglobin levels 60 CoFactor 60 nucleotide analogue 60 genotypic resistance 60 baminercept 60 etanercept 60 LCP Tacro 60 ELACYT 60 HMG CoA reductase inhibitors 60 REYATAZ R 60 eluting stent 60 dose statin therapy 60 lopinavir ritonavir Kaletra 60 grade cervical lesions 60 rituximab Rituxan 60 metaglidasen 60 favorable pharmacokinetic profile 60 previously untreated follicular 60 adjuvant hormonal therapy 60 resected pancreatic cancer 60 ceftazidime 60 nanomolar range 60 LHRH agonist 60 adjuvant radiotherapy 60 cediranib 60 pharmacodynamic PD 60 Aeroquin 60 mcg doses 60 forodesine 60 Losartan 60 tenofovir DF 60 gliclazide 60 plus COPEGUS 60 metastatic RCC 60 neoplasia CIN 60 potent CYP#A# inhibitors 60 Pegylated interferon 60 hydroxymethyl coenzyme 60 transaminases 60 RRMS patients 60 bolus injection 60 interferon IFN 60 ZOLINZA 60 levetiracetam 60 Kaplan Meier analysis 60 lenalidomide Revlimid ® 60 blinded randomized placebo controlled 60 serum concentrations 60 mg BID dose 60 BRAF inhibitor 60 doxazosin 60 infliximab 60 KRAS mutant tumors 60 DAVANAT 60 FOLFIRINOX 60 CA4P 60 conventional DMARDs 60 oral prednisone 60 plus DOXIL 60 imatinib Gleevec ® 60 tiotropium bromide 60 TNF antagonists 60 care regimens CCR 60 Leukine ® 60 oral prodrug 60 abiraterone acetate 60 salmeterol fluticasone propionate 60 hENT1 60 pharmacodynamics PD 60 cetuximab Erbitux ® 60 lispro alone 60 Candesartan 60 VICTRELIS 60 SCIg 60 anastrozole 60 talabostat 60 GHRH 60 bronchodilation 60 TELINTRA 60 miconazole Lauriad ® 60 tumor lysis syndrome 60 nonmetastatic prostate cancer 60 rHuEPO 60 canakinumab 60 Q#IR 60 Pioglitazone 60 low dose ritonavir 60 chemotherapy FOLFOX 60 mg TID 60 peginterferon alfa 2a #KD 60 HuMax EGFr 60 oxymorphone ER 60 PURE proprietary 60 erythropoietic 60 biphasic insulin aspart 60 tamoxifen Nolvadex ® 59 dosing cohorts 59 oral antidiabetic medication 59 Degarelix 59 folinic acid 59 somatostatin analogue 59 alanine aminotransferase ALT 59 AVASTIN 59 PegIntron 59 immunosuppressive regimen 59 antiplatelet agent 59 CLARITY study 59 aspartate aminotransferase 59 ZYVOX 59 glycosylated hemoglobin levels 59 Nilotinib 59 microgram kg 59 abiraterone 59 HER2 positive metastatic breast 59 hypofractionated 59 FOLFOX chemotherapy 59 pegylated interferon alfa 2a 59 BEXXAR Therapeutic Regimen 59 Imprime PGG 59 Bevacizumab Avastin 59 glulisine 59 molecular weight heparins 59 microg 59 GnRH agonists 59 aminotransferase elevations greater 59 Traficet EN 59 Aplidin 59 primary patency 59 cetuximab Erbitux R 59 novel histone deacetylase 59 plasma triglycerides 59 serum LDL cholesterol 59 phase Ib 59 serum folate 59 relapsed CLL 59 INTELENCE 59 locoregional disease 59 NEVO ™ 59 somatostatin analog 59 systemic corticosteroid 59 Taxotere R 59 ACE inhibitors beta blockers 59 epoetin alfa 59 MVax 59 aliskiren 59 VcMP 59 omega interferon 59 direct thrombin inhibitors 59 q8h 59 mTOR inhibitors 59 deferiprone 59 RoACTEMRA 59 cytoreduction 59 β blockers 59 lopinavir r arm 59 anti leukemic 59 hepatic insulin sensitivity 59 zoledronate 59 TNF Tumor Necrosis Factor 59 injected subcutaneously 59 inhaled iloprost 59 HBeAg negative patients 59 baseline HbA1c 59 lamivudine 59 glycoprotein IIb IIIa inhibitors 59 donepezil Aricept 59 haematologic 59 esophageal candidiasis 59 daily Infergen 59 DFMO 59 potentially hepatotoxic 59 Atrasentan 59 transdermal estradiol 59 mTOR inhibitor 59 #.#/#.# mmHg [001] 59 chemoembolization 59 trastuzumab Herceptin R 59 imatinib Gleevec 59 PD LID 59 isoproterenol 59 cyclophosphamide methotrexate 59 rhGH 59 achieved CCyR 59 Dabigatran etexilate 59 bosutinib 59 MIRCERA 59 tyrosine kinase inhibitor 59 liver metastasis 59 continuous intravenous infusion 59 oxaliplatin Eloxatin 59 antiangiogenic therapy 59 MDS AML 59 TNF inhibitor 59 methotrexate 59 Faslodex 59 docetaxel prednisone 59 mg dose 59 FOLFOX regimen 59 μg dose 59 allogeneic stem cell 59 clopidogrel Plavix 59 serum phosphorus 59 nucleoside analog 59 busulfan 59 pioglitazone 59 sipuleucel T